Multidrug resistance in cancer: understanding molecular mechanisms, immunoprevention and therapeutic approaches

TB Emran, A Shahriar, AR Mahmud, T Rahman… - Frontiers in …, 2022 - frontiersin.org
Cancer is one of the leading causes of death worldwide. Several treatments are available for
cancer treatment, but many treatment methods are ineffective against multidrug-resistant …

Recent advances in engineered materials for immunotherapy‐involved combination cancer therapy

JL Liang, GF Luo, WH Chen, XZ Zhang - Advanced Materials, 2021 - Wiley Online Library
Immunotherapy that can activate immunity or enhance the immunogenicity of tumors has
emerged as one of the most effective methods for cancer therapy. Nevertheless, single …

Progress in tumor-associated macrophage (TAM)-targeted therapeutics

C Ngambenjawong, HH Gustafson, SH Pun - Advanced drug delivery …, 2017 - Elsevier
As an essential innate immune population for maintaining body homeostasis and warding
off foreign pathogens, macrophages display high plasticity and perform diverse supportive …

Neutrophils in aging and aging‐related pathologies

K Van Avondt, JK Strecker, C Tulotta… - Immunological …, 2023 - Wiley Online Library
Over the past millennia, life expectancy has drastically increased. While a mere 25 years
during Bronze and Iron ages, life expectancy in many European countries and in Japan is …

Triggered all-active metal organic framework: ferroptosis machinery contributes to the apoptotic photodynamic antitumor therapy

X Meng, J Deng, F Liu, T Guo, M Liu, P Dai, A Fan… - Nano …, 2019 - ACS Publications
Nanoscale photodynamic therapy (PDT) is an appealing antitumor modality for which
apoptosis is the major mechanism of toxicity induction. It was postulated that the highly …

Metal drugs and the anticancer immune response

B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …

Mechanisms of immune evasion in breast cancer

JP Bates, R Derakhshandeh, L Jones, TJ Webb - BMC cancer, 2018 - Springer
Tumors develop multiple mechanisms of immune evasion as they progress, with some
cancer types being inherently better at 'hiding'than others. With an increased understanding …

Paraptosis inducer to effectively trigger immunogenic cell death for metastatic tumor immunotherapy with IDO inhibition

RR Zheng, LP Zhao, CY Huang, H Cheng, N Yang… - ACS …, 2023 - ACS Publications
Paraptosis is characterized by the extensive vacuolization of endoplasmic reticulum (ER)
and mitochondria, which will cause the release of damage-associated molecular patterns to …

Anthracyclines as topoisomerase II poisons: from early studies to new perspectives

J Marinello, M Delcuratolo, G Capranico - International journal of …, 2018 - mdpi.com
Mammalian DNA topoisomerases II are targets of anticancer anthracyclines that act by
stabilizing enzyme-DNA complexes wherein DNA strands are cut and covalently linked to …

Chemotherapeutic drug-induced immunogenic cell death for nanomedicine-based cancer chemo–immunotherapy

M Jiang, J Zeng, L Zhao, M Zhang, J Ma, X Guan… - Nanoscale, 2021 - pubs.rsc.org
Chemotherapy has been a conventional paradigm for cancer treatment, and multifarious
chemotherapeutic drugs have been widely employed for decades with significant …